Corbus Pharmaceuticals Receives FDA Orphan Drug Designation for Lenabasum for the Treatment of Dermatomyositis Pharmaceutical Investing
Kalytera and Former Shareholders of Talent Biotechs Agree to Deferment of Milestone Payments Cannabis Investing News
Kalytera to Enter Medical Cannabis Market With Focus on Treatment of Psoriasis and Menstrual Cramps Cannabis Investing News
BioCure Technology Inc. Provides Update on Pre-Clinical Trial of Interferon-beta 1b. Biotech Investing